title: Expression of vitamin D receptor decreases during progression of pigmented skin lesions.
abstract: 1,25-dihydroxyvitamin D3 affects proliferation, differentiation, and apoptosis and protects DNA against oxidative damage with a net tumorostatic and anticarcinogenic effect. It acts through a specific nuclear receptor that is widely distributed through the body. Although a beneficial role of vitamin D in melanoma patients has been suggested, there is lack of information on the changes in the expression pattern of vitamin D receptor during progression of pigmented lesions. Using immunohistochemistry, we analyzed the expression of vitamin D receptor in 140 samples obtained form 82 patients, including 25 benign nevi, 70 primary cutaneous melanomas, 35 metastases, 5 re-excisions, and 5 normal skin biopsies. The strongest expression was observed in normal skin that significantly decreased in melanocytic proliferations with the following order of expression: normal skin > melanocytic nevi > melanomas = metastases. The vitamin D receptor expression in skin surrounding nevi and melanoma was also significantly reduced as compared to normal skin. Tumor-infiltrating and lymph node lymphocytes retained high levels of vitamin D receptor. There was negative correlation between tumor progression and vitamin D receptor expression with a remarkable decrease of the immunoreactivity in nuclei of melanoma cells at vertical versus radial growth phases and with metastatic melanomas showing the lowest cytoplasmic receptor staining. Furthermore, lack of the receptor expression in primary melanomas and metastases was related to shorter overall patients' survival. In addition, the receptor expression decreased in melanized melanoma cells in comparison to amelanotic or poorly pigmented cells. Therefore, we propose that reduction or absence of vitamin D receptor is linked to progression of melanocytic lesions, that its lack affects survival of melanoma patients, and that melanogenesis can attenuate receptor expression. In conclusion, changes in vitamin D receptor expression pattern can serve as important variables for diagnosis, predicting clinical outcome of the disease, and/or as a guidance for novel therapy of melanomas based on use of vitamin D or its derivatives.
authors.affiliation: Department of Tumor Pathology and Pathomorphology, The Lukaszczyk Oncology Center, The Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz 85-796, Poland.
authors.forename: Anna A
authors.initials: AA
authors.lastname: Brożyna
authors.forename: Wojciech
authors.initials: W
authors.lastname: Jozwicki
authors.forename: Zorica
authors.initials: Z
authors.lastname: Janjetovic
authors.forename: Andrzej T
authors.initials: AT
authors.lastname: Slominski
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017209:Apoptosis; D002467:Cell Nucleus / Q000378:metabolism; D018450:Disease Progression; D004547:Elastic Tissue / Q000473:pathology / Q000528:radiation effects; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008543:Melanins / Q000096:biosynthesis; D008545:Melanoma / Q000378:metabolism / Q000401:mortality / Q000473:pathology / Q000556:secondary; D008875:Middle Aged; D008938:Mitosis; D009508:Nevus, Pigmented / Q000378:metabolism / Q000473:pathology; D010859:Pigmentation Disorders / Q000378:metabolism* / Q000473:pathology*; D018167:Receptors, Calcitriol / Q000172:deficiency / Q000378:metabolism*; D012867:Skin / Q000378:metabolism / Q000473:pathology; D012878:Skin Neoplasms / Q000378:metabolism / Q000401:mortality / Q000473:pathology / Q000556:secondary; D015996:Survival Rate; D014407:Tumor Cells, Cultured; D014466:Ultraviolet Rays / Q000009:adverse effects; D055815:Young Adult
chemical_list: D008543:Melanins; D018167:Receptors, Calcitriol